Glaukos Corporation Glaukos Corporation

Glaukos Corporation

GKOS

Ранг среди акций #1965
Glaukos Corporation operates as an ophthalmic medical technology and... Glaukos Corporation operates as an ophthalmic medical technology and pharmaceutical enterprise, primarily focused on pioneering novel therapies for glaucoma, corneal disorders, and retinal diseases. The company offers a range of micro-bypass stents, including iStent, iStent inject, and iStent inject W. These devices are designed to enhance aqueous humor outflow, being inserted during cataract surgery to treat mild-to-moderate open-angle glaucoma. Its promising product pipeline features iStent Infinite, a three-stent system intended for standalone use in patients with refractory glaucoma, as well as iDose TR, a targeted injectable implant that utilizes Glaukos's micro-scale device platform to deliver therapeutic levels of medication. The company distributes its products through a direct sales organization and a network of distributors, serving markets across the United States and internationally. Glaukos Corporation, founded in 1998, is headquartered in San Clemente, California.
Цена акции
$177.09
Последняя синхронизация: 2026-10-21
Рыночная капитализация
$10.45B
Изменение (1 день)
1.76%
Изменение (1 год)
131.10%
Страна
US
Торговля Glaukos Corporation (GKOS)

Категория

Healthcare
История цены акций Glaukos Corporation (GKOS)
Наивысшая цена закрытия: $166.80 2026-10-01

Наименьшая цена закрытия: $29.05 2015-06-01
История цены акций Glaukos Corporation с 2015 по 2026
Годовая динамика цены акций
Год Результативность
2026 (TTM) 16.37%
2025 -22.38%
2024 97.91%
2023 64.84%
2022 1.09%
2021 -38.87%
2020 24.29%
2019 -5.51%
2018 133.10%
2017 -22.73%
2016 38.93%
2015 0.00%
Цена акций похожих компаний или конкурентов
Компания Цена акций Изменение 1г% Страна
$100.56 -21.41%
US
$93.07 -2.95%
IE
$297.13 -23.49%
US
$44.47 -57.18%
US
$46.95 -18.05%
DE